Insiders Buying Rani Therapeutics And 1 Other Stock

Although US stocks closed lower on Friday, there were a few notable insider trades.

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.

Rani Therapeutics

• The Trade: Rani Therapeutics Holdings, Inc. RANI 10% owner South Lake One LLC acquired a total of 4,467 shares an average price of $5.47. To acquire these shares, it cost around $24.45 thousand.
• What’s Happening: Rani Therapeutics posted in-line loss for its fourth quarter.
• What Rani Therapeutics Does: Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics.

flooidCX

• The Trade: flooidCX Corp. FLCX CEO Dennis M Danzik acquired a total of 1,200 shares at an average price of $4.04. To acquire these shares, it cost around $4.85 thousand.
• What’s Happening: flooidCX shares around 378% over the past month.
• What flooidCX Does: FlooidCX Corp acts as an online complaint resolution platform for consumers and businesses. The company offers unified communications and collaboration in online CRM solutions - GripeVine and Resolution1.

Don’t forget to check out our premarket coverage here

Check This Out: Fear & Greed Index Remains In 'Greed' Zone Following Economic Data